With shares of General Electric (NYSE:GE) trading around $27, is GE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementGeneral Electric is a diversified industrial, technology, and financial services company that operates worldwide. The products and services of the company range from aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products. General Electric�� segments are Energy Infrastructure, Aviation, Healthcare, Transportation, Home & Business Solutions, and GE Capital. General Electric is a leading provider of a wide range of products and many are essential in daily lives of consumers and companies around the world.
General Electric on Monday continued its push to expand its healthcare operation, agreeing to acquire certain life science assets of Thermo Fisher Scientific for $1.06 billion in cash.�The deal includes Waltham, Mass.-based Thermo Fisher’s cell culture, gene modulation, and magnetic bead businesses. The units, part of Thermo Fisher’s analytical technologies segment, generated combined revenue of about $250 million in 2013.�Fairfield, Conn.-based GE has been seeking to refocus its sprawling collection of businesses since the economic downturn, and looking to divest its consumer finance operations and to grow in healthcare and energy. The company said the Thermo Fisher units would be folded into its $4 billion-sales GE Healthcare life sciences business, giving it a more complete portfolio of tools used for cell biology research, cell therapy and for the manufacture of new biological medicines and vaccines.
Top 10 Dow Dividend Companies To Watch For 2015: Harris & Harris Group Inc.(TINY)
Harris & Harris Group, Inc. is a venture capital and venture debt firm specializing in seed, start up, early stage, and mid venture investments. It primarily invests in tiny-technology-enabled companies with a focus on nanotechnology, microsystems, and microelectromechanical systems technology. Harris & Harris Group, Inc. was founded in 1981 and is based in New York, New York with additional offices in Palo Alto, California and Los Angeles, California.
Advisors' Opinion:- [By Sally Jones]
Highlight: Harris & Harris Group Inc. (TINY)
The TINY share price is currently $3.07 or 22.1% off the 52-week high of $3.94. The company does not pay a dividend.
10 Best Life Sciences Stocks To Own Right Now: Horizon Pharma Inc (HZNP)
Horizon Pharma, Inc. (Horizon), incorporated on March 23, 2010, is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company�� other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company�� distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation. On April 1, 2010, Horizon effected a recapitalization and acquisition pursuant to which Horizon Pharma, Inc. became a holding company, that operates through its wholly owned subsidiaries, Horizon Pharma USA, Inc. (formerly Horizon Therapeutics, Inc.) and Horizon Pharma AG (formerly Nitec Pharma AG (Nitec)).
DUEXIS
DUEXIS is a combination of 800 milligram ibuprofen and 26.6 milligram famotidine in a single pill and is indicated for the relief of signs and symptoms of rheumatoid arthritis (RA), and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal (GI), ulcers in patients who are taking ibuprofen for those indications. The Company has completed two Phase III clinical trials in a total of over 1,500 patients with mild to moderate pain or arthritis that demonstrated a significant reduction in the incidence of non-steroidal anti-inflammatory drugs (NSAID)-induced upper GI ulcers when treated with DUEXIS versus ibuprofen alone.
LODOTRA
LODOTRA is a programmed release formulation of low-dose prednisone, a well-established drug use! d to inhibit the production of various pro-inflammatory cytokines, which are proteins associated with joint inflammation in RA. LODOTRA has received regulatory approval in Europe for the treatment of moderate to severe, active RA in adults when accompanied by morning stiffness. As of December 31, 2010, the Company had completed two pivotal Phase III clinical trials of LODOTRA in a total of over 600 patients with RA. The first pivotal Phase III trial supported the approval of LODOTRA in Europe in March 2009, where it is approved for marketing in 14 European countries. LODOTRA achieved significant results and met the primary endpoint in each of the two pivotal Phase III clinical trials. Its LODOTRA product was developed and is owned by Horizon Pharma AG. As of December 31, 2010, the Company markets LODOTRA in Europe through three separate agreements. Pursuant to two separate agreements, it granted Merck Serono GmbH and Merck GesmbH, an affiliate of Merck Serono, the rights to distribute and market LODOTRA in each of Germany and Austria, respectively, and pursuant to the third agreement, it granted Mundipharma rights to distribute and market LODOTRA in the rest of Europe. The Company also has a manufacturing and supply agreement with Jagotec AG under which Jagotec or its affiliates manufacture and supply LODOTRA to the Company as bulk tablets.
The Company competes with Pfizer Inc., Pozen Inc., Abbott Laboratories and Amgen Inc.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.
Top Headline
The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million. - [By Lisa Levin]
Horizon Pharma (NASDAQ: HZNP) shares reached a new 52-week high of $17.12 after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent. - [By Jake L'Ecuyer]
Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.
Top Headline
The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million.
10 Best Life Sciences Stocks To Own Right Now: Pinnacle Financial Partners Inc.(PNFP)
Pinnacle Financial Partners, Inc. operates as the bank holding company for Pinnacle National Bank that provides commercial banking products and services to individuals, small-to medium-sized businesses, and professional entities in Tennessee. It offers various deposit products, including savings, checking, interest-bearing checking, money market, and certificate of deposit accounts. The company also offers commercial loans comprising equipment loans and working capital loans; commercial and residential real estate loans, and construction and development loans; and loans to individuals for personal, family, investment, and household purposes, including secured and unsecured installment and term loans, residential first mortgage loans, home equity loans, and home equity lines of credit. In addition, it provides various investment products, such as mutual funds, variable annuities, money market instruments, the United States treasury securities, bonds, fixed annuities, stocks , financial planning, asset management accounts, and listed options; fiduciary and investment management services for individual and commercial clients, including personal trust, endowments, foundations, individual retirement accounts, pensions, and custody services; investment advisory services; and insurance products primarily in the property and casualty area. Further, the company offers telephone and Internet banking, debit cards, automated teller machines, remote and direct deposit, and cash management services. As of January 17, 2012, it operated 29 offices in 8 Middle Tennessee counties and 3 offices in Knoxville. The company was founded in 2000 and is headquartered in Nashville, Tennessee.
Advisors' Opinion:- [By Brian Pacampara]
What: Shares of Pinnacle Financial (NASDAQ: PNFP ) climbed 10% today after the regional bank's quarterly results topped Wall Street expectations.
10 Best Life Sciences Stocks To Own Right Now: The Babcock & Wilcox Co (BWC)
The Babcock & Wilcox Company (B&W), incorporated on March 8, 2010, is a technology innovator in power generation systems, a specialty constructor of nuclear components and a service provider in its segments. The Company provides a variety of products and services to customers in the power and other steam-using industries, including electric utilities and other power generators, industrial customers in various other industries, and the United States Government. The Company operates in four business segments: Power Generation, Nuclear Operations, Technical Services and Nuclear Energy.
Power Generation
Through Power Generation segment, the Company supplies boilers fired with fossil fuels, such as coal, oil and natural gas, or renewable fuels, such as biomass, municipal solid waste and concentrated solar energy. In addition, the Company supplies environmental equipment and components and related services to customers in different regions around the world. The Company designs , engineers, manufactures, supplys, constructs and services utility and industrial power generation systems, including boilers used to generates steam in electric power plants, pulp and paper making, chemical and process applications and other industrial uses.
Power Generation segment specializes in engineering, manufacturing, procurement and erection of equipment used in the power generation industry and various other industries, and the provision of related services, including engineered-to-order services, products and systems for energy conversion worldwide and related auxiliary equipment, such as burners, pulverizers, soot blowers and ash handling systems; heavy-pressure equipment for energy conversion, such as boilers fueled by coal, oil, bitumen, natural gas, municipal solid waste, biomass and other fuels; environmental control systems, including both wet and dry scrubbers for flue gas desulfurization, modules for selective catalytic reduction of the oxides of nitrogen, equipment to capture! particulate matter, such as fabric filter baghouses and wet and dry electrostatic precipitators, and similar devices, and power plant equipment and related heavy mechanical erection services.
The Company supports primarily fossil operating plants with a variety of additional services, including the installation of new systems and replacement parts, engineering services, construction, inspection, maintenance and field technical services, such as condition assessments and inventory services. The Company offers a range of construction services through a wholly owned subsidiary including erection of utility and industrial boiler plants and installations of cogeneration facilities and pollution control equipment, such as selective catalytic reduction systems and flue gas desulfurization scrubbers.
The Company also provides power through cogeneration, refuse-fueled power plants and other independent power-producing facilities. In this market, the Company owns and operates facilities, supply equipment and serve as contractors for engineer-procure-construct services and operations and maintenance.
Nuclear Operations
Through Nuclear Operations segment, the Company engineers , design and manufactures precision naval nuclear components and reactors for the United States Department of Energy (DOE)/National Nuclear Security Administration's (NNSA) Naval Nuclear Propulsion Program.The Company's Nuclear Operations segment specializes in the design and manufacture of close-tolerance and equipment for nuclear applications. In addition, the Company is a manufacturer of critical nuclear components, fuels and assemblies for government and limited commercial uses. The Company also converts or downblend high-enriched uranium into low-enriched fuel for uses in commercial reactors to generate electricity. The Company has also been a provider in the receipt, storage, characterization, dissolution, recovery and purification of a variety of uranium-bearing materials. All phases! of urani! um downblending and uranium recovery are provided at the Company's Lynchburg, Virginia and Erwin, Tennessee sites.
The Company works closely with the DOE-supported nuclear non-proliferation program. This program is assisting in the development of a high-density, low-enriched uranium fuel required for high-enriched uranium test reactor conversions.
Technical Services
Through Technical Services segment, the Company provides various services to the United States Government, including uranium processing, environmental site restoration services and management and operating services for various United States Government-owned facilities. These services are provided to the DOE, including the NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
The Company�� principal operations include managing and operating nuclear production facilities; managing and operating environmental management sites; managing spent nuclear fuel and transuranic waste for the DOE, and providing critical skills and resources for DOE sites.The Company manages and operates complex, high-consequence nuclear and national security operations for the DOE and the NNSA, primarily through its joint ventures. The Company's Technical Services segment's overall activity primarily depends on authorized spending levels of the DOE, NNSA, the Office of Nuclear Energy, the Office of Science, the Department of Defense and the Office of Environmental Management.
Nuclear Energy
Through Nuclear Energy segment, the Company supplies commercial nuclear steam generators and components to nuclear utility customers. In addition, this segment offers a full spectrum of services for steam generators and balance of plant equipment, as well as nondestructive examination and tooling/repair solutions for other plant systems and components. The Company's Nuclear Energy segment fabricates pressure vessels, reactors, stea! m generat! ors, heat exchangers and other auxiliary equipment. This segment also provides specialized engineering and maintenance services and power plant construction. This segment specializes in performing full scope, prototype design work coupled with manufacturing integration. The Company is developing the B&W mPower reactor, a small modular reactor design with the flexibility to provide between 180 megawatts to greater than 1,000 megawatts of electrical power generation (in increments of 180 megawatts) and the capacity to operate for a four year operating cycle without refueling.
The Company competes with Alstom S.A., Doosan Babcock, Babcock Power, Inc., Foster Wheeler AG., Hitachi, Ltd., Bechtel National, Inc., URS Corporation, CH2M Hill, Inc., Fluor Corporation, Lockheed Martin Corporation, Jacobs Engineering Group, Inc., AREVA Inc., EnergySolutions, Inc. and Northrop Grumman Corporation.
Advisors' Opinion:- [By The Energy Report]
JH: One of the areas where the U.S. for decades has been the leading technological power is in small nuclear reactors. We've used them on our aircraft carriers and on our nuclear submarines safely and efficiently. The U.S. has an advantage in understanding small modular nuclear reactors. One of the companies that we have followed for a long time that's working on that is Babcock & Wilcox Co. (BWC). There's also Fluor Corp. (FLR), which is working on small modular nuclear reactors. President Obama and the Department of Energy are funding research on the implementation of small modular nuclear reactors.
10 Best Life Sciences Stocks To Own Right Now: ManpowerGroup(MAN)
ManpowerGroup provides workforce solutions and services worldwide. The company offers permanent, temporary, and contract recruitment services; assessment and selection services; training and development services; outsourcing services; and workforce consulting services. It also provides professional resourcing and project-based workforce solutions in the information technology, finance, and engineering fields; talent and career management workforce solutions; and talent based outsourcing services, managed services, recruitment process outsourcing services, borderless talent solutions, and strategic workforce consulting services. The company was founded in 1948 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By idahansen]
The more I read about how companies are responding to Obamacare, the more bullish I become for stocks in the demand labor market such as Labor SMART (OTCBB: LTNC), Paychex (NASDAQ: PAYX), and ManpowerGroup (NYSE: MAN).
- [By Jonathan Buck]
The prospects of Adecco, which competes with the likes of� Manpower (MAN) and Randstad Holding (RANJY), are closely tied to growth in gross domestic product, so an improvement in the economic outlook for Europe is good news. In the euro zone, comprising the 17 countries that use the common currency, GDP shrank 0.4% in 2013, according to forecasts. It is expected to grow 1.1% in 2014. That�� an important turnaround: the euro zone has seen positive growth in on two of the past five years.
- [By Monica Gerson]
ManpowerGroup (NYSE: MAN) is expected to report its Q3 earnings at $1.08 per share on revenue of $5.08 billion.
Celanese (NYSE: CE) is estimated to report its Q3 earnings at $1.04 per share on revenue of $1.59 billion.
10 Best Life Sciences Stocks To Own Right Now: Accuray Incorporated(ARAY)
Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company offers the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Alex Planes]
Intuitive Surgical's stock has been battered by worse-than-expected third-quarter results, which included the first year-over-year quarterly revenue decline in company history, coming on the heels of an underwhelming second quarter this summer. Fool contributor Rupert Hargreaves notes that the FDA's initiated an investigation on Intuitive's da Vinci surgical robotics systems, after it found several discrepancies in its incident reports. As a result, quarterly sales of the da Vinci declined from 155 units to 101 units, a drop that can only be partly blamed on slowing demand for medical devices in the U.S. Intuitive may have underperformed compared to recently acquired MAKO Surgical (NASDAQ: MAKO ) and Accuray (NASDAQ: ARAY ) over the past year, but it remains the 800-pound gorilla among these industry peers.
- [By John Udovich]
Small cap robotic stock Adept Technology (NASDAQ: ADEP) has put in a very good performance this month verses its immediate peer�iRobot Corporation (NASDAQ: IRBT) as well as against medical robotic stocks like MAKO Surgical (NASDAQ: MAKO), Accuray Incorporated (NASDAQ: ARAY) and Hansen Medical, Inc (NASDAQ: HNSN). I should also mention that we have recently added Adept Technology to our SmallCap Network Elite Opportunity (SCN EO) portfolio (we are up 9% since last week) because we feel robotics is an improving sector as companies aim to reduce overhead and improve efficiencies through machine to machine (M2M) automation.
- [By John Udovich]
Yesterday, small cap medical robotics stock MAKO Surgical Corp (NASDAQ: MAKO) soared 82.19% after it was announced that Stryker Corporation (NYSE: SYK) would acquire it���meaning it might be time to take a closer look at large cap medical robotics leader Intuitive Surgical, Inc (NASDAQ: ISRG) along with small caps Accuray Incorporated (NASDAQ: ARAY) and Hansen Medical, Inc (NASDAQ: HNSN). MAKO Surgical Corp�markets both its RIO Robotic Arm Interactive Orthopedic System and proprietary RESTORIS family of implants to surgeons for a procedure called MAKOplastythat provides a less invasive method for knee resurfacing and a new procedure for Total Hip Arthroplasty.�Stryker Corporation, whose medical technologies include reconstructive, medical and surgical, and neurotechnology and spine products, agreed to pay $1.65 billion or $30 a share for a massive 86%�premium for MAKO Surgical Corp. That�� sounds great for investors unless you are an investor who go in the stock back in 2011 and early 2012 when shares hit as high as the�$43 level.
10 Best Life Sciences Stocks To Own Right Now: General Communication Inc.(GNCMA)
General Communication, Inc. provides communication services to residential and business customers under the GCI and Alaska Wireless brand names in Alaska. The company?s Consumer segment provides local and long distance voice services; video services and products, including cable, high-definition television, digital video recorder, premium channel programming, video on demand, and pay-per-view programming services; Internet access; and fixed and mobile wireless voice and data services. This segment also sells handsets, personal computer wireless data cards, and accessories to residential customers; and offers bundled services and products, which comprise long-distance, cable television, cable modem Internet access, local access, and wireless services. Its Network Access segment provides interstate and intrastate-switched message telephone, multi-protocol label switching, frame relay, private line and dedicated Internet, and wireless services to GSM and CDMA wireless carrie rs. The company?s Commercial segment offers local and long distance communication, video, Internet, data network, managed, wireless, and bundled products and services. Its Managed Broadband segment offers Internet access, data network, and managed services to rural school districts, hospitals, and health clinics. The company?s Regulated Operations segment provides wireline communications services, including local access and long-distance, and Internet services and products, to residential, business, and governmental customers in areas of rural Alaska. General Communication, Inc. sells its services primarily through direct contact marketing, as well as through local media advertising, and its retail stores and Website. As of December 31, 2011, it had approximately 87,900 long-distance customers, 138,100 local access lines in service, 142,600 basic cable subscribers, 139,900 wireless subscribers, and 119,400 cable modem subscribers. The company was founded in 1979 and is bas ed in Anchorage, Alaska.
Advisors' Opinion:- [By Lisa Levin]
Long Distance Carriers: This industry fell 1.97% by 10:50 am ET. General Communication (NASDAQ: GNCMA) shares dropped 2.2% in today's trading. General Communication's trailing-twelve-month profit margin is 0.98%.
- [By Dan Radovsky]
Alaska Communications and General Communication (NASDAQ: GNCMA ) -- also known as GCI -- have finalized the transaction they proposed last summer to form The Alaska Wireless Network, or AWN, both companies announced today.
- [By Dan Radovsky]
Alaska Communications and General Communications, (NASDAQ: GNCMA ) , or GCI, today signed the network sharing agreement they proposed last summer.
No comments:
Post a Comment